Table 3 Incidence of patients who noticed glare symptoms or cyanopsia at 2 weeks and at 3 months after surgery.
| Yellow IOL | Non‐tinted IOL | p Value | |
|---|---|---|---|
| Glare symptoms | |||
| 2 weeks | 2 (5.3%) | 2 (5.6%) | >0.9999* |
| 3 months | 3 (7.9%) | 2 (5.6%) | >0.9999* |
| Cyanopsia | |||
| 2 weeks | 0 (0%) | 5 (13.9%) | 0.0234† |
| 3 months | 0 (0%) | 0 (0%) | – |
*No significant difference, †Statistically significant difference.